About: Strategies to manage hepatitis C virus (HCV) disease burden     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis suggests that successful diagnosis and treatment of a small proportion of patients can contribute significantly to the reduction of disease burden in the countries studied. The largest reduction in HCV-related morbidity and mortality occurs when increased treatment is combined with higher efficacy therapies, generally in combination with increased diagnosis. With a treatment rate of approximately 10%, this analysis suggests it is possible to achieve elimination of HCV (defined as a >90% decline in total infections by 2030). However, for most countries presented, this will require a 3-5 fold increase in diagnosis and/or treatment.
  • The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis suggests that successful diagnosis and treatment of a small proportion of patients can contribute significantly to the reduction of disease burden in the countries studied. The largest reduction in HCV-related morbidity and mortality occurs when increased treatment is combined with higher efficacy therapies, generally in combination with increased diagnosis. With a treatment rate of approximately 10%, this analysis suggests it is possible to achieve elimination of HCV (defined as a >90% decline in total infections by 2030). However, for most countries presented, this will require a 3-5 fold increase in diagnosis and/or treatment. (en)
Title
  • Strategies to manage hepatitis C virus (HCV) disease burden
  • Strategies to manage hepatitis C virus (HCV) disease burden (en)
skos:prefLabel
  • Strategies to manage hepatitis C virus (HCV) disease burden
  • Strategies to manage hepatitis C virus (HCV) disease burden (en)
skos:notation
  • RIV/00216224:14110/14:00075456!RIV15-MSM-14110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, V
http://linked.open...iv/cisloPeriodika
  • Supplement 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 47662
http://linked.open...ai/riv/idVysledku
  • RIV/00216224:14110/14:00075456
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • diagnosis; epidemiology; HCV; mortality; treatment; scenarios; prevalence; incidence; hepatitis C; disease burden (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [163439FA7C2C]
http://linked.open...i/riv/nazevZdroje
  • JOURNAL OF VIRAL HEPATITIS
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 21
http://linked.open...iv/tvurceVysledku
  • Buti, M.
  • Cornberg, M.
  • Husa, Petr
  • Moreno, C.
  • Akarca, U.
  • Balik, I.
  • Berg, T.
  • Bihl, F.
  • Bilodeau, M.
  • Blasco, A. J.
  • Bruggmann, P.
  • Calinas, F.
  • Calleja, J. L.
  • Cheinquer, H.
  • Christensen, P. B.
  • Clausen, M.
  • Coelho, H. S. M.
  • Correa, M. C. Mendes
  • Cramp, M. E.
  • Dore, G. J.
  • Doss, W.
  • Duberg, A. S.
  • El-Sayed, M. H.
  • Ergör, G.
  • Esmat, G.
  • Estes, C.
  • Falconer, K.
  • Ferraz, M. L. G.
  • Ferreira, P. R.
  • Frankova, S.
  • Félix, J.
  • García-Samaniego, J.
  • Gerstoft, J.
  • Giria, J. A.
  • Gonçales, F. L. Jr.
  • Gschwantler, M.
  • Hofer, H.
  • Hézode, C.
  • Idilman, R.
  • Kaita, K. D. E.
  • Kautz, A.
  • Kaymakoglu, S.
  • Krajden, M.
  • Krarup, H.
  • Kåberg, M.
  • Laleman, W.
  • Lavanchy, D.
  • Lázaro, P.
  • Marinho, R. T.
  • Marotta, P.
  • Mauss, S.
  • Mello, C. E. Brandão
  • Myers, R. P.
  • Müllhaupt, B.
  • Nemecek, V.
  • Parkes, J.
  • Peltekian, K. M.
  • Pessôa, M. Guimarães
  • Ramji, A.
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software